ID NOW™ COVID-19 Assay

The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene.

Notify me on updates of this product 

Availability: Commercially Available

+1 224 667 6100
100 Abbott Park Road
Abbott Park, Ill. 60064
USA
www.abbott.com/
Manufacturer
Abbott Laboratories
Product Name
ID NOW™ COVID-19 Assay
Detection Category
Biological
Detection Principle
Molecular;
Detection Method
Assays;Nucleic Acid Amplification;
Application
Detection;Diagnostics;
Equipment Type
Diagnostic
Product Synopsis
The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene.
Availability
Commercially Available
Technology Readiness Level (TRL)
9
Market Entry Date
April 2020
User Feedback Sources
Indifferent/No user feedback
No Information Is Available
Transportability
Benchtop/Fixed; Small Footprint
Other Biological Targets
SARS-CoV-2
Response Time (Sample Application To Output)
<15 minutes
No Information Is Available
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: